Colgate-Palmolive (NYSE:CL) reported Q2 EPS of $0.72, $0.01 better than the analyst estimate of $0.71. Revenue for the quarter came in at $4.48 billion versus the consensus estimate of $4.36 billion.
GUIDANCE:
The Company raised its organic sales growth guidance for full year 2022 to 5% to 7%